Announcements Trials
Browse Landscape

Phase

Phase 2 24Phase 1 10Phase 1/2 6Phase 3 2Phase EARLY_PHASE1 1Phase 2/3 1

Status

Unknown 11Completed 6Terminated 2Recruiting 2Active not recruiting 2Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Lymphoma, Large B-Cell, Diffuse 1Leukemia, Myeloid, Acute 1

Interventions

Carboplatin 98Cisplatin 95pembrolizumab 91Gemcitabine 81Paclitaxel 79Docetaxel 70Capecitabine 64Oxaliplatin 53Fluorouracil 51Specimen Handling 50Magnetic Resonance Spectroscopy 49Bevacizumab 49Radiotherapy 48Dexamethasone 45Cyclophosphamide 45Drug Therapy 39Leucovorin 38Doxorubicin 37Pemetrexed 35Irinotecan 34Injections 30Rituximab 29Vincristine 28Trastuzumab 26Radiosurgery 26Prednisone 26Lenalidomide 25Etoposide 25130-nm albumin-bound paclitaxel 25Radiation 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Recruiting × Decitabine × Clear all
NCT05586074 2026-04-28

HEC73543 Versus Salvage Chemotherapy in R/R FLT3-ITD AML

Sunshine Lake Pharma Co., Ltd.

Phase 3 Recruiting
324 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT05351346 2023-03-24

Genotype-guided Treatment in DLBCL

Ruijin Hospital

Phase 3 Recruiting
1,100 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡